Carotid Endarterectomy Versus Carotid Artery Stenting? A Prospective Comparison of Neuropsychological Outcome in Patients With Carotid Stenosis.
1 other identifier
interventional
100
1 country
1
Brief Summary
In this prospective study, patients with carotid stenosis will be randomly assigned to one of the two surgical procedures (carotid endarterectomy (CEA) and carotid stenting (CAS)). Pre- and postoperative neuropsychological functions, levels of several biomarkers and intraoperative embolization load will be examined. In a subgroup of patients, MRI-data will also be gathered. The mix of these data will allow us to answer several questions regarding the absence or presence of preoperative impairments, postoperative changes in cognitive performance and possible differences between CEA and CAS regarding postoperative neuropsychological functions. The use of a matched control group and implementation of a long term follow-up will contribute to the uniqueness of this study. It will meet several flaws of previous studies and will complete the ongoing randomized studies comparing CEA and CAS that are lacking neuropsychological data.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2011
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2011
CompletedFirst Submitted
Initial submission to the registry
April 15, 2011
CompletedFirst Posted
Study publicly available on registry
April 18, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2015
CompletedDecember 1, 2021
November 1, 2021
4 years
April 15, 2011
November 18, 2021
Conditions
Outcome Measures
Primary Outcomes (4)
Pre-operative neuropsychological state
Pen and paper tests will be performed.
pre-operative
Post-operative neuropsychological state (3 weeks)
Pen and paper tests will be performed.
after 3 weeks
Post-operative neuropsychological state (6 months)
Pen and paper tests will be performed.
after 6 months
Post-operative neuropsychological state (1 year)
Pen and paper tests will be performed.
after 1 year
Secondary Outcomes (10)
Levels of biomarkers pre-operatively
pre-operatively, intra-operative, after 2 hours, 6 hours and 24 hours
Determination of cardiovascular risks pre-operatively
pre-operatively
Determination of cardiovascular risks after 3 weeks
after 3 weeks
Determination of cardiovascular risks after 6 months
after 6 months
Determination of cardiovascular risks after 1 year
after 1 year
- +5 more secondary outcomes
Study Arms (3)
Carotid endarterectomy (CEA)
EXPERIMENTALPatients with carotid stenosis who are randomly assigned to a carotid endarterectomy.
Carotid Stenting (CAS)
EXPERIMENTALPatients with carotid stenosis who are randomly assigned to a carotid stenting.
matched control group
NO INTERVENTIONMatched control group.
Interventions
Carotid endarterectomy (CEA) will be performed on the patients
Carotid Stenting (CAS) will be performed on these patients.
Neurocognitive functions will be measured pre-operatively and after 3 weeks, 6 months and 1 year.
Levels of biomarkers (Protein S100B) will be examined pre- , peri- and post-operatively after 2 hours, 6 hours and 24 hours.
A Transcranial Doppler Ultrasonography will be used to detect peri-operative embolization.
On a subgroup of 20 patients a MRI-scan will be done pre- and post-operatively after 48 hours and 3 weeks.
Eligibility Criteria
You may qualify if:
- Patients with carotid stenosis.
You may not qualify if:
- Significant medical conditions which affect neurocognitive functions (e.g. cancer, epilepsy)
- Older than 80 years
- A history of psychiatric or neurological illness
- Severe alcohol of drug abuse
- Coronary artery bypass graft (CABG) less than a year ago.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Ghentlead
- University Hospital, Ghentcollaborator
Study Sites (1)
Ghent University Hospital
Ghent, Belgium
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Frank Vermassen, Ph.D., M.D.
University Hospital, Ghent
- PRINCIPAL INVESTIGATOR
Guy Vingerhoets, Ph.D., Professor
University Ghent
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 15, 2011
First Posted
April 18, 2011
Study Start
April 1, 2011
Primary Completion
April 1, 2015
Study Completion
September 1, 2015
Last Updated
December 1, 2021
Record last verified: 2021-11